GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Middle East Pharmaceutical Industries Co (SAU:4016) » Definitions » ROA %

Middle East Pharmaceutical Industries Co (SAU:4016) ROA % : 3.22% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Middle East Pharmaceutical Industries Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Middle East Pharmaceutical Industries Co's annualized Net Income for the quarter that ended in Sep. 2024 was ﷼15.5 Mil. Middle East Pharmaceutical Industries Co's average Total Assets over the quarter that ended in Sep. 2024 was ﷼480.0 Mil. Therefore, Middle East Pharmaceutical Industries Co's annualized ROA % for the quarter that ended in Sep. 2024 was 3.22%.

The historical rank and industry rank for Middle East Pharmaceutical Industries Co's ROA % or its related term are showing as below:

SAU:4016' s ROA % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 5.35
Current: 5.35

During the past 0 years, Middle East Pharmaceutical Industries Co's highest ROA % was 5.35%. The lowest was 0.00%. And the median was 0.00%.

SAU:4016's ROA % is ranked better than
66.44% of 1034 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs SAU:4016: 5.35

Middle East Pharmaceutical Industries Co ROA % Historical Data

The historical data trend for Middle East Pharmaceutical Industries Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Middle East Pharmaceutical Industries Co ROA % Chart

Middle East Pharmaceutical Industries Co Annual Data
Trend
ROA %

Middle East Pharmaceutical Industries Co Quarterly Data
Jun23 Sep23 Jun24 Sep24
ROA % - - 18.72 3.22

Competitive Comparison of Middle East Pharmaceutical Industries Co's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Pharmaceutical Industries Co's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Middle East Pharmaceutical Industries Co's ROA % distribution charts can be found below:

* The bar in red indicates where Middle East Pharmaceutical Industries Co's ROA % falls into.



Middle East Pharmaceutical Industries Co ROA % Calculation

Middle East Pharmaceutical Industries Co's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Middle East Pharmaceutical Industries Co's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=15.468/( (465.958+494.042)/ 2 )
=15.468/480
=3.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Middle East Pharmaceutical Industries Co  (SAU:4016) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=15.468/480
=(Net Income / Revenue)*(Revenue / Total Assets)
=(15.468 / 324.244)*(324.244 / 480)
=Net Margin %*Asset Turnover
=4.77 %*0.6755
=3.22 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Middle East Pharmaceutical Industries Co ROA % Related Terms

Thank you for viewing the detailed overview of Middle East Pharmaceutical Industries Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Middle East Pharmaceutical Industries Co Business Description

Traded in Other Exchanges
N/A
Address
8146 King Muhammad V, Sulaimaniyah, P.O. Box 4180, Riyadh, SAU, 11491
Website
Middle East Pharmaceutical Industries Co is a holding company is engaged in manufacturing medicines, medicated and non-medicated creams and gels.

Middle East Pharmaceutical Industries Co Headlines

No Headlines